Inspirata Acquires GE's Omnyx, Expands Digital Pathology Portfolio

Jan 31, 2018

|

NEW YORK (360Dx) – Inspirata said today that it has acquired Pittsburgh-based Omnyx from GE Healthcare in a deal that will enable it to deliver an IVD device for primary diagnosis in Europe and Canada.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Inspirata Acquires GE's Omnyx, Expands Digital Pathology Portfolio

To read the full story....

Breaking News

FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

BTIG Initiates Coverage of Fulgent Genetics

Tangen Biosciences, LabWare Partner on Point-of-Care Coronavirus Kit

Progenity Files for IPO, Seeks to Raise up to $100M

LetsGetChecked At-Home Molecular SARS-CoV-2 Test Nabs FDA Emergency Use Authorization

OraSure Technologies to Acquire HIV Drug Adherence Test Developer UrSure

What's Popular?

Progenity Files for IPO, Seeks to Raise up to $100M

Coronavirus Antibody Test Distribution Deal Inked by MedMira, Webb Diagnostic

OraSure Technologies to Acquire HIV Drug Adherence Test Developer UrSure

Tangen Biosciences, LabWare Partner on Point-of-Care Coronavirus Kit

Biolytical Awarded C$633K to Develop One-Minute COVID-19 Antibody Test

Sponsorships